NORTHAMPTON, MA / ACCESSWIRE / January 5, 2023 / Quest Diagnostics
It's difficult to overestimate the toll that the COVID-19 pandemic has had on many of our nation's children-academically, socially, developmentally, and emotionally. Quest Diagnostics recognizes the critical role that daily in-school learning plays in helping our kids to overcome the very real challenges they faced with repeated lockdowns, school closings, and the limitations of remote learning.
In our commitment to supporting communities throughout the country, Quest has established multiple initiatives, including:
Quest's "Back to the Classroom" program as well as additional COVID-19 testing initiatives, are also helping college students, faculty, and staff safely return to and stay on campus.
View additional multimedia and more ESG storytelling from Quest Diagnostics on 3blmedia.com.
Contact Info:
Spokesperson: Quest Diagnostics
Website: https://www.3blmedia.com/profiles/quest-diagnostics
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$167.69 |
Daily Change: | -0.40 -0.24 |
Daily Volume: | 114,765 |
Market Cap: | US$18.720B |
June 10, 2025 April 22, 2025 April 09, 2025 April 02, 2025 |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREAstria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREEnd of content
No more pages to load